RE:RE:It's key..."Raising money is difficult in any environment for poorly run companies. Guess who can raise money in any environment??"
And Gilles finds a deal that arguably finances CZO at $1.25 per share which is a substantial premium to the market price and with no warrants. Gilles deal even impressed arguably the most important biotech executive in Canada the last twenty years: Ronnie Miller is "thrilled". Furthermore, Gilles positioned himself on the inside of AEZS so he knew exactly when to pull the trigger as a diagnostic deal was being negotiated.